NCT05710328 2026-03-02
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
Clinical Trials
18 trialsNCT04024462 2026-02-20
A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT06135714 2026-02-11
OLIGAMI
Tokyo Medical and Dental University
Phase 3 Recruiting
NCT05415215 2026-02-10
ProHer
Hoffmann-La Roche
Phase 3 Completed
NCT02926911 2026-01-27
COMET
Alliance Foundation Trials, LLC.
Phase NA Active not recruiting
NCT04770272 2026-01-12
neoMono
Palleos Healthcare GmbH
Phase 2 Terminated
NCT05278741 2025-12-26
BREAST
Centre Georges Francois Leclerc
Phase NA Active not recruiting
NCT00929214 2025-12-17
Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT01723774 2025-12-09
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Washington University School of Medicine
Phase 2 Active not recruiting
NCT07253168 2025-11-28
TIGER-BC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Not yet recruiting
NCT05890677 2025-11-14
LYMPH
University Hospital, Basel, Switzerland
Phase NA Recruiting
NCT05929768 2025-11-05
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
SWOG Cancer Research Network
Phase 3 Recruiting
NCT07016399 2025-10-30
Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC
Vanderbilt-Ingram Cancer Center
Phase 2 Recruiting
NCT02807597 2025-08-17
Real-time Intraoperative Breast Cancer Visualization for Margin Assessment
University of Texas Southwestern Medical Center
Phase 1/2 Terminated
NCT07071402 2025-08-15
A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery
Xijing Hospital
Phase NA Recruiting
NCT06027541 2025-08-03
Young Patients With Early Breast Cancer
Peking Union Medical College Hospital
Active not recruiting
NCT06914440 2025-07-15
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
Xijing Hospital
Phase 2 Recruiting
NCT03725059 2025-07-11
KEYNOTE-756
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting